ClassID:

95037

C07D311/04 - CPC Classification

Classification description:

Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems Benzo[b]pyrans, not hydrogenated in the carbocyclic ring

Sub-classes:
Recent Application in this class:
#1
20250326777
2025-10-23

COMPOUNDS, COMPOSITIONS AND METHODS THEREOF

#2
20250059153
2025-02-20

BICYCLIC QUINONES, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS

#3
20240391892
2024-11-28

A SMALL MOLECULE COMPOUND AND ITS USE AND PREPARATION METHOD

#4
20240325340
2024-10-03

ISOFORM SPECIFIC AGONISTS TARGETING AKT KINASE

#5
20240317699
2024-09-26

A PROCESS FOR THE PURIFICATION OF ANTHOCYANINS AND ANTHOCYANIDINS FROM NATURAL EXTRACTS USING ADSORPTION RESINS AND ACIDIFIED WATER AS DESORBENT

#6
20240150330
2024-05-09

CHROMANS AND BENZOFURANS AS 5-HT1A AND TAAR1 AGONISTS

#7
20240043396
2024-02-08

METHODS OF TREATING OCULAR FIBROTIC PATHOLOGIES

#8
20230226062
2023-07-20

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

#9
20230129488
2023-04-27

Composition for inhibiting alpha-glucosidase and application thereof

#10
20220348821
2022-11-03

SYSTEMS AND METHODS FOR ELECTROCHROMIC MOLECULES

#11
20220220087
2022-07-14

ANTHOCYANIN EXTRACTION METHODS

#12
20210339164
2021-11-04

LIQUID PRODUCTION METHOD AND LIQUID PRODUCTION DEVICE

#13
20210214329
2021-07-15

Nutrients to enhance load-induced muscle hypertrophy

#14
20210163438
2021-06-03

SYNTHESIS OF PHYTOCANNABINOIDS INCLUDING A DEMETHYLATION STEP

#15
20210085805
2021-03-25

FLUOROPHORES FOR SUPER-RESOLUTION IMAGING

#16
20210061781
2021-03-04

PROCESS FOR THE PRODUCTION OF CANNABIDIOL AND DELTA-9-TETRAHYDROCANNABINOL

#17
20200199142
2020-06-25

3-phenyl-2,3,4,8,9,10-hexahydropyrano[2,3-f]chromene derivative and method for synthesizing optical isomer thereof

#18
20200172496
2020-06-04

Triazoles as Kv3 inhibitors

#19
20200048272
2020-02-13

Method for synthesizing 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2.3-f]chromene derivative and optical isomer of thereof

#20
20190367495
2019-12-05

Antidiabetic heterocyclic compounds

#21
20190254316
2019-08-22

Composition for browning inhibition and use of same

#22
20190233429
2019-08-01

Conformationally-constrained bioisosteres of caffeic acid, and synthesis and therapeutic uses

#23
20190071405
2019-03-07

Triazoles as Kv3 inhibitors

#24
20190047977
2019-02-14

Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof

#25
20190037843
2019-02-07

Substituted 2,3-dihydrobenzofuran compounds and their use as synergists

#26
20180334442
2018-11-22

CHROMENE DERIVATIVES AND THEIR ANALOGS AS WNT PATHWAY ANTAGONISTS

#27
20180319763
2018-11-08

Process for the production of cannabidiol and delta-9-tetrahydrocannabinol

#28
20180244640
2018-08-30

Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use

#29
20180221427
2018-08-09

Transdermal formulations for delivery of capsaicinoids

#30
20180179388
2018-06-28

METHODS OF ANTHOCYANIN EXTRACTION FROM COLORED CORN CULTIVARS

#31
20180148427
2018-05-31

Phenol derivatives to treat cancer

#32
20180099977
2018-04-12

Inhibitors of histone deacetylase

#33
20180072697
2018-03-15

Therapeutic compounds

#34
20180022696
2018-01-25

N-acyl-arylsulfonamide derivatives as aminoacyl-tRNA synthetase inhibitors

#35
20180016282
2018-01-18

INHIBITORS OF HISTONE DEACETYLASE

#36
20180002307
2018-01-04

PARTIALLY SATURATED TRICYCLIC COMPOUNDS AND METHODS OF MAKING AND USING SAME

#37
20170349563
2017-12-07

Formation of chromanes based on intermolecular reaction of alkynes with dimethylfuran in the presence of gold(I) complexes

#38
20170313673
2017-11-02

Chromene-2 derivatives and use thereof in the treatment of fibrosis

#39
20170217920
2017-08-03

Antidiabetic bicyclic compounds

#40
20170216739
2017-08-03

Method of extracting nutrients from a plant

#41
20170174672
2017-06-22

Fused (hetero)cyclic compounds as S1P modulators

#42
20170146533
2017-05-25

Compounds comprising one or more hydrophobic domains and a hydrophilic domain comprising peg moieties, useful for binding cells

#43
20170073321
2017-03-16

Enzyme-specific fluorescent compound capable of being retained in cells

#44
20170050180
2017-02-23

N-substituted pyridiniophosphines, processes for their preparation and their use

#45
20170008868
2017-01-12

Process for the production of cannabidiol and delta-9-tetrahydrocannabinol

#46
20170001973
2017-01-05

Partially saturated tricyclic compounds and methods of making and using same

#47
20160355496
2016-12-08

Chromene derivatives and their analogs as Wnt pathway antagonists

#48
20160347761
2016-12-01

Inhibitors of histone deacetylase

#49
20160318882
2016-11-03

Triazoles as KV3 inhibitors

#50
20160272611
2016-09-22

Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof

#51
20160251351
2016-09-01

Inhibitors of histone deacetylase

#52
20160229831
2016-08-11

SUBSTITUTED 3-PHENYLPROPYLAMINE DERIVATIVES FOR THE TREATMENT OF OPHTHALMIC DISEASES AND DISORDERS

#53
20160152543
2016-06-02

Inhibitors of viral replication, their process of preparation and their therapeutical uses

#54
20160137659
2016-05-19

Chromane and chromene derivatives and their use as CRAC modulators

#55
20160102070
2016-04-14

Anhydrous crystalline form of -equol

#56
20160100579
2016-04-14

NEMATICIDAL N-(2-SUBSTITUTED 2-PHENYLETHYL)CARBOXAMIDES AND N-(2-SUBSTITUTED 2-PHENYLETHYL)-THIOCARBOXAMIDES

#57
20160075652
2016-03-17

Synthetic analogues of xanthohumol

#58
20160068542
2016-03-10

Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells

#59
20160060239
2016-03-03

Geranyl flavonoid derivative with improved water solubility, a method for preparing the same, and a method for treating cancer using the same

#60
20160002255
2016-01-07

Antidiabetic bicyclic compounds

#61
20150336866
2015-11-26

SYNTHESIS OF DIFLUOROMETHYL ETHERS AND SULFIDES

#62
20150274718
2015-10-01

Inhibitors of viral replication, their process of preparation and their therapeutical uses

#63
20150225539
2015-08-13

Bio-based polymer additive, a process for preparing the bio-based polymer additive and a biodegradable polymer composition comprising said bio-based polymer additive

#64
20150119418
2015-04-30

Bicyclic compound

#65
20150111910
2015-04-23

Triazoles as Kv3 inhibitors

#66
20150057456
2015-02-26

Process for producing (S)-equol

#67
20150038573
2015-02-05

Anti-obesity agent comprising compound containing benzotropolone ring

#68
20150005514
2015-01-01

Process for the production of 4-substituted chromanes via gold catalysis

#69
20140221342
2014-08-07

6-substituted phenoxychroman carboxylic acid derivatives

#70
20140155636
2014-06-05

Process of separating chiral isomers of chroman compounds and their derivatives and precursors

#71
20140121388
2014-05-01

ANTI-OBESITY AGENT COMPRISING COMPOUND CONTAINING BENZOTROPOLONE RING

#72
20140094512
2014-04-03

METHOD OF MODULATING THE DEGREE OF ADIPOSE TISSUE DEPOSITED INTRAMUSCULARLY

#73
20130303550
2013-11-14

Chromene derivatives and their analoga as Wnt pathway antagonists

#74
20130296344
2013-11-07

CHROMENE DERIVATIVES AND THEIR ANALOGA AS WNT PATHWAY ANTAGONISTS

#75
20130211080
2013-08-15

Process for the manufacture of TMHQ

#76
20130203830
2013-08-08

Compounds for Prevention of Cell Injury

#77
20130165479
2013-06-27

ANTAGONISTS OF THE TRPV1 RECEPTOR AND USES THEREOF

#78
20130158067
2013-06-20

TRPV1 antagonists

#79
20130116275
2013-05-09

Inhibitors of HIF and angiogenesis

#80
20120295923
2012-11-22

Aminocyclohexanes and Aminotetrahydropyrans and Related Compounds As Gamma-Secretase Modulators

#81
20120253036
2012-10-04

AGENT FOR TREATING FIBROMYALGIA

#82
20120220780
2012-08-30

Ligand for asymmetric synthesis catalyst, and process for production of alpha-alkenyl cyclic compound using the same

#83
20120065410
2012-03-15

Anti-obesity agent comprising compound containing benzotropolone ring

#84
20120004427
2012-01-05

Method for enantioselective hydrogenation of chromenes

#85
20120003270
2012-01-05

6-SUBSTITUTED ISOFLAVONOID COMPOUNDS AND USES THEREOF

#86
20110237803
2011-09-29

Process for preparing synthetic intermediates of peripherally-selective inhibitors of dopamine-β-hydroxylase involving catalytic asymmetric hydrogenation

#87
20110207729
2011-08-25

BICYCLIC ACYLGUANIDINE DERIVATIVE

#88
20110190330
2011-08-04

Spirocyclic GPR40 modulators

#89
20110166360
2011-07-07

Catalytic Process for Asymmetric Hydrogenation

#90
20110130384
2011-06-02

AMIDE COMPOUND

#91
20110112303
2011-05-12

Process for preparing intermediates of peripherally-selective inhibitors of dopamine-β-hydroxylase involving catalytic asymmetric hydrogenation

#92
20110105463
2011-05-05

6-substituted phenoxychroman carboxylic acid derivatives

#93
20100298580
2010-11-25

Process for the Preparation of 2H-Chromene-3-Carbamate Derivatives

#94
20100298579
2010-11-25

Process for preparing synthetic cannabinoids

#95
20100267754
2010-10-21

INTEGRIN EXPRESSION INHIBITOR

#96
20100197686
2010-08-05

Therapeutic compounds

#97
20100160425
2010-06-24

ANTI-ALLERGIC AGENT AND BEVERAGE/FOOD, PREPARATION FOR EXTERNAL APPLICATION OR COSMETIC COMPRISING THE AGENT

#98
20100137329
2010-06-03

Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the FAAH enzyme

#99
20100069653
2010-03-18

Method for enantioselective hydrogenation of chromenes

#100
20100041656
2010-02-18

Amide derivatives and medicinal use thereof

#101
20100009927
2010-01-14

Anti-Inflammatory and Anti-Allergy Extracts from Nettle

#102
20090326015
2009-12-31

Compounds with embedded benzopyran motif for core structures and preparation method thereof

#103
20090253715
2009-10-08

Heteroaryl-containing isoflavones as aromatase inhibitors

#104
20090203667
2009-08-13

PENTADIENAMIDE DERIVATIVES

#105
20090099236
2009-04-16

3-amino-1-arylpropyl indoles and AZA-substituted indoles and uses thereof

#106
20090076076
2009-03-19

Inhibitors of cysteine proteases and methods of use thereof

#107
20090012074
2009-01-08

Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

#108
20080293792
2008-11-27

Tocopherol derivatives and uses thereof

#109
20080182891
2008-07-31

CHROMANE AND CHROMENE DERIVATIVES AND USES THEREOF

#110
20070213316
2007-09-13

N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives

#111
20070123527
2007-05-31

3-amino-1-arylpropyl indoles and aza-substituted indoles and uses thereof

#112
20070037874
2007-02-15

Manufacturing process of isoflavan or isoflavene derivatives

#113
20070027329
2007-02-01

Method for enantioselective hydrogenation of chromenes

#114
20060293310
2006-12-28

Derivatives of 1-piperazine-and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the FAAH enzyme

#115
20060270726
2006-11-30

Phenyl substituted cyclic derivatives

#116
20060258714
2006-11-16

Chromane and chromene derivatives and uses thereof

#117
20060247283
2006-11-02

Pesticidal (dihalopropenyl)phenylalkyl substituted benzodioxolane and benzodioxole derivatives

#118
20060223879
2006-10-05

Non-steroidal farnesoid x receptor modulators

#119
20060183923
2006-08-17

Heteroaryl-containing isoflavones as aromatase inhibitors

#120
20060128764
2006-06-15

Non-steroidal farnesoid X receptor modulators and methods for the use thereof

#121
20060094776
2006-05-04

Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives

#122
20060089404
2006-04-27

PPAR alpha selective compounds for the treatment of dyslipidemia and other lipid disorders

#123
20060063843
2006-03-23

Compounds for the treatment of inflammatory disorders

#124
20060020023
2006-01-26

Racemization method

#125
20060020022
2006-01-26

Enantioselective separation method

#126
20050176750
2005-08-11

Substituted 4H-chromens, 2H-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof

#127
20050176712
2005-08-11

Integrin expression inhibitor

#128
20050171356
2005-08-04

Pesticidal (dihalopropenyl) phenylalkyl substituted benzoxazole and benzothiazole derivatives

#129
20050143449
2005-06-30

Non-steroidal farnesoid X receptor modulators and methods for the use thereof

#130
20050080021
2005-04-14

Nitric oxide donating derivatives of stilbenes, polyphenols and flavonoids for the treatment of cardiovascular disorders